Open Government Portal
Found 10 records similar to Likelihood of various measures being permanently adopted once the pandemic is over, by business characteristics, third quarter of 2020
Support for workers, considerations for businesses navigating COVID-19 disruptions, Economic Response Plan, guidance for federal employees.
COVID-19 is a new disease. A vaccine or therapy to treat or prevent this disease has not yet been developed. However, the COVID-19 pandemic has resulted in a global review of therapies that may be used to treat or prevent the disease. Canada is speeding up the importation and sale of medical devices used to diagnose, treat or prevent COVID-19.
COVID-19 vaccine ingredients in the Pfizer-BioNTech, Moderna and AstraZeneca vaccines.
COVID-19 is a new disease not previously identified in humans. Currently there is no vaccine or therapeutic product for COVID-19 that is authorized to treat or prevent the disease. The outbreak of COVID-19 has resulted in a global review of therapies that could be used to treat or prevent the infection. In an effort to facilitate earlier access to a vaccine, or therapeutic product for COVID-19, the Department will expedite the review of any COVID-19 related health product submissions and applications.
Variant strains of SARS-CoV-2 are emerging that may affect the level of protection provided by currently authorized COVID-19 vaccines. As a result, manufacturers are adapting authorized COVID-19 vaccines to provide protection against infection and disease caused by virus variants.
This page presents detailed information on Canada's whole-of-government actions to respond to the COVID-19 outbreak.
"The Cyber Centre has seen an increase in reports of malicious actors using the CoronaVirus (COVID-19) in phishing campaigns and malware scams.
The response to COVID-19 is being led by Public Health Agency of Canada (PHAC), with support from public health officials and agencies across Canada. For information about COVID-19 please visit the Government of Canada’s COVID-19 Outbreak Update page for the most up to date information."
Likelihood of businesses or organizations permanently adopting various measures once the COVID-19 pandemic is over, by North American Industry Classification System (NAICS), business employment size, type of business, business activity and majority ownership, second quarter of 2021.
As of June 16, all COVID-19 datasets will be updated weekly on Thursdays by 2pm. This dataset details the percentage of COVID-19 positive patients in hospitals and ICUs for COVID-19 related reasons, and for reasons other than COVID-19. Data includes: * reporting date * percentage of COVID-19 positive patients in hospital admitted for COVID-19 * percentage of COVID-19 positive patients in hospital admitted for other reasons * percentage of COVID-19 positive patients in ICU admitted for COVID-19 * percentage of COVID-19 positive patients in ICU admitted for other reasons Due to incomplete weekend and holiday reporting, data for hospital and ICU admissions are not updated on Sundays, Mondays and the day after holidays. This dataset is subject to change.
Impact of COVID-19 on the status of the businesses and organizations, by North American Industry Classification System (NAICS), business employment size, type of business, business activity and majority ownership.